Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00677079
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Peritoneal Cancer
Advanced Epithelial Ovarian Cancer
Interventions
DRUG:
Iniparib
Sponsor
Sanofi